Vaughn Himes
Director/Board Member en ACHIEVE LIFE SCIENCES, INC. .
Fortuna: - $ al 29/02/2024
Perfil
En la actualidad, Vaughn B. Himes ocupa el cargo de Director Técnico de Seagen Inc. En su trayectoria profesional anterior fue Vicepresidente Senior de Operaciones Técnicas en ZymoGenetics, Inc., Vicepresidente de Operaciones de Fabricación en AmpliPhi Biosciences Corp., Vicepresidente de Fabricación a nivel mundial en Corixa Corp., Vicepresidente de Desarrollo de Productos en Genovo, Inc. y Director Asociado de Desarrollo Biológico en Wyeth Lederle Vaccines SA. Vaughn B. Himes se licenció en el Pomona College y se doctoró en la Universidad de Minnesota.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
22/01/2024 | 0 ( -.--% ) | - $ | 29/02/2024 | |
VBI VACCINES, INC.
-.--% | 27/07/2023 | 0 ( -.--% ) | - $ | 29/02/2024 |
Cargos activos de Vaughn Himes
Empresas | Cargo | Inicio |
---|---|---|
ACHIEVE LIFE SCIENCES, INC. | Director/Board Member | 14/03/2022 |
VBI VACCINES INC. | Director/Board Member | 24/04/2023 |
Antiguos cargos conocidos de Vaughn Himes.
Empresas | Cargo | Fin |
---|---|---|
SEAGEN INC. | Chief Operating Officer | 01/07/2012 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | 01/03/2009 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | 01/10/2005 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/03/2003 |
Genovo, Inc.
Genovo, Inc. Medical SpecialtiesHealth Technology Part of Innoviva, Inc., Genovo, Inc. is a maker of gene and cell therapy products. The private company is based in Sharon Hill, PA. Genovo was acquired by AmpliPhi Biosciences Corp. on September 20, 2000 for $84.53 million. | Corporate Officer/Principal | 01/01/2000 |
Formación de Vaughn Himes.
Pomona College | Undergraduate Degree |
University of Minnesota | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
VBI VACCINES INC. | Health Technology |
ACHIEVE LIFE SCIENCES, INC. | Health Technology |
Empresas privadas | 6 |
---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Genovo, Inc.
Genovo, Inc. Medical SpecialtiesHealth Technology Part of Innoviva, Inc., Genovo, Inc. is a maker of gene and cell therapy products. The private company is based in Sharon Hill, PA. Genovo was acquired by AmpliPhi Biosciences Corp. on September 20, 2000 for $84.53 million. | Health Technology |
Wyeth Lederle Vaccines SA
Wyeth Lederle Vaccines SA Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Wyeth Lederle Vaccines SA develops and manufactures pharmaceutical products. The private company is based in Louvain-la-Neuve, Belgium. | Health Technology |